Incidence of Mortality and Complications After Lung Surgery, Open Thoracic Aortic Repair, TEVAR, EVAR.

Incidence of Perioperative Mortality and Major Complications in Patients Who Underwent Lung Surgery, Open Thoracic Aortic Repair, Thoracic Endovascular Aortic Repair (TEVAR), and Endovascular Aortic Repair (EVAR). A Retrospective Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05073991

Enrollment

2224

Registered

2021-10-12

Start date

2021-10-23

Completion date

2023-12-31

Last updated

2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morality, Lung Cancer, Aortic Aneurysm, Aortic Dissection

Keywords

Mortality, Major complications, Lung surgery, Open aortic surgery, Thoracic endovascular aortic repair, Endovascular aneurysm repair

Brief summary

Lung surgery, open aortic surgery, TEVAR, and EVAR are major operations that carry a higher incidence of perioperative mortality and complications compare to other surgery. The study of the incidence of mortality and complications will help the hospital to benchmark with the others. Also the study of the risk factors of mortality and major complications will help to improve the patients' outcomes.

Interventions

PROCEDURELung surgery

Patients underwent lung surgery including wedge resection, lobectomy, segmentectomy, and pneumonectomy.

PROCEDUREOpen aortic surgery

Patients underwent open thoracic surgery or thoracoabdominal aortic surgery.

PROCEDURETEVAR

Patients underwent TEVAR.

PROCEDUREEVAR

Patients underwent EVAR.

Study design

Observational model

FAMILY_BASED

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Patients underwent * thoracic surgery * open thoracic aortic surgery * TEVAR * EVAR

Exclusion criteria

* Emergency lung surgery * Conversion from TEVAR to open thoracic surgery * Conversion from EVAR to open aortic surgery

Design outcomes

Primary

Measure	Time frame	Description
Incidence of mortality and major complications after TEVAR	30 days	The mortality and major complications (CVS, CNS, RS and others) will be recorded.
Incidence of mortality and major complications after open aortic surgery	30 days	The mortality and major complications (CVS, CNS, RS and others) will be recorded.
Incidence of mortality and major complications after EVAR	30 days	The mortality and major complications (CVS, CNS, RS and others) will be recorded.
Incidence of mortality and major complications after lung surgery	30 days	The mortality and major complications (CVS, CNS, RS and others) will be recorded.

Secondary

Measure	Time frame	Description
Risk factors of mortality and major complications after TEVAR	30 days	To identify risk factors eg. smoking, diagnosis, age, etc.
Risk factors of mortality and major complications after lung surgery	30 days	To identify risk factors eg. smoking, type of surgery, age, etc.
Risk factors of mortality and major complications after open aortic surgery	30 days	To identify risk factors eg. smoking, type of surgery, age, etc.
Risk factors of mortality and major complications after EVAR	30 days	To identify risk factors eg. smoking, age, etc.

Other

Measure	Time frame	Description
Incidence of postoperative delirium	30 days	The patients with postoperative delirium required treatment will be described.
Risk factors of postoperative stroke.	30 days	To identify risk factors eg. smoking, type of surgery, age, etc.
Incidence of low muscle mass	7 days	Psoas muscle index will be used for the diagnosis of low muscle mass. Psoas muscle index = both psoas muscle area at L3 (from CT scan) divided by body surface area. Cut-off values of sarcopenia * Male 68.5 cm2/m2 * Female 52.5 cm2/m2

Countries

Thailand

Contacts

Primary ContactSirilak Suksompong, MD

sirilak.suk@mahidol.ac.th66891534806

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026